Correlation Between Krystal Biotech and Phathom Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Krystal Biotech and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Phathom Pharmaceuticals.
Diversification Opportunities for Krystal Biotech and Phathom Pharmaceuticals
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Krystal and Phathom is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Phathom Pharmaceuticals go up and down completely randomly.
Pair Corralation between Krystal Biotech and Phathom Pharmaceuticals
Given the investment horizon of 90 days Krystal Biotech is expected to generate 0.7 times more return on investment than Phathom Pharmaceuticals. However, Krystal Biotech is 1.43 times less risky than Phathom Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 7,678 in Krystal Biotech on November 1, 2024 and sell it today you would earn a total of 8,027 from holding Krystal Biotech or generate 104.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Krystal Biotech vs. Phathom Pharmaceuticals
Performance |
| Timeline |
| Krystal Biotech |
| Phathom Pharmaceuticals |
Krystal Biotech and Phathom Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Krystal Biotech and Phathom Pharmaceuticals
The main advantage of trading using opposite Krystal Biotech and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.| Krystal Biotech vs. MeiraGTx Holdings PLC | Krystal Biotech vs. Apellis Pharmaceuticals | Krystal Biotech vs. Regenxbio | Krystal Biotech vs. Rhythm Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |